The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury (Q39450580)
Jump to navigation
Jump to search
scientific article published on 3 December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury |
scientific article published on 3 December 2009 |
Statements
1 reference
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury (English)
1 reference
Chris Frost
1 reference
Ian Roberts
1 reference
Yashbir Dewan
1 reference
Bennie Hartzenberg
1 reference
Francisco Murillo-Cabezas
1 reference
Laura Balica
1 reference
Ramalingam R Ravi
1 reference
Peter Andrews
1 reference
Toomas Asser
1 reference
Cristian Boeriu
1 reference
Juan Diego Ciro Quintero
1 reference
Patrick Druwé
1 reference
Olivia Fletcher
1 reference
Jorge Mejia Mantilla
1 reference
Jan Pachl
1 reference
Indrek Rätsep
1 reference
Cristina Sampaio
1 reference
Manmohan Singh
1 reference
Petr Svoboda
1 reference
3 December 2009
1 reference
1 December 2009
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference